Daratumumab (with recombinant human hyaluronidase)
Product Description
Hangzhou Jiuyuan Genetic Biopharmaceutic
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:5
-
Employees:1000 - 4999
Company types
Categories
Specifications
Hangzhou Jiuyuan Genetic Biopharmaceutic
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:5
-
Employees:1000 - 4999
Company types
More Products from Hangzhou Jiuyuan Genetic Biopharmaceutic (18)
-
Product Filgrastim
Filgrastim, Neupogen, G-CSF, Indicated to neutropenia, Formulated bulk liquid, l Injection (ampoule/PFS/vial) 75µg/unit, 150µg/unit, 300µg/unit, 450µg/unit
-
Product Fosaprepitant dimeglumine
cancerbrhrbrEmend, CAS number: 265121-04-8 -
Product Amylin analog
Weight management -
Product Avatrombopag maleate
thrombocytopeniaTablet: 20mg per tablet -
Product Bone repair material with rhBMP-2 - Bone repair
a new bone repair material， registered as an implanted medical device
-
Product Daratumumab
Multiple myeloma (CD-38 mab) -
Product Dulaglutide
diabetes (recombinant route) -
Product Emicizumab
Type A hemophilia with factor VIII inhibitors -
Product Enoxaparin Sodium
anticoagulant and antithrombotic, the most widely accepted LMWH by doctors
-
Product Fulvestrant
an anti-cancer drug, Bulk and injection (PFS): 250mg in 5ml
-
Product Palonosetron Hydrochloride
anti-emesis after chemotherapy or radio therapy Palonosetron, Aloxi,
Injection (ampoule): 0.25mg/5ml， 0.075mg/1.5ml
-
Product Palonosetron Hydrochloride
anti-emesis after chemotherapy or radiotherapy, Active pharmaceutical ingredient (API) , Injection (ampoule): 0.25mg/5ml